Jump to content

R-spondin 1

From Wikipedia, the free encyclopedia
(Redirected from RSPO1)
RSPO1
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesRSPO1, CRISTIN3, RSPO, R-spondin 1
External IDsOMIM: 609595; MGI: 2183426; HomoloGene: 52148; GeneCards: RSPO1; OMA:RSPO1 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001038633
NM_001242908
NM_001242909
NM_001242910
NM_173640

NM_138683

RefSeq (protein)

NP_001033722
NP_001229837
NP_001229838
NP_001229839

NP_619624

Location (UCSC)Chr 1: 37.61 – 37.63 MbChr 4: 124.88 – 124.9 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

R-spondin-1 is a secreted protein that in humans is encoded by the RSPO1 gene, found on chromosome 1.[5] In humans, it interacts with WNT4 in the process of female sex development. Loss of function can cause female to male sex reversal.[6] Furthermore, it promotes canonical WNT/β catenin signaling.[7]

Structure

[edit]

The protein has two cysteine-rich, furin-like domains and one thrombospondin type 1 domain.[5]

Function

[edit]

Sex Development

[edit]

Early Gonads

[edit]

RSPO1 is required for the early development of gonads, regardless of sex. It has been found in mice only eleven days after fertilization.[6] To induce cell proliferation, it acts synergistically with WNT4.[6] They help stabilize β-catenin, which activates downstream targets. If both are deficient in XY mice, there is less expression of SRY and a reduction in the amount of SOX9. Moreover, defects in vascularization are found. These occurrences result in testicular hypoplasia. Male to female sex reversal, however, does not occur because Leydig cells remain normal. They are maintained by steroidogenic cells, now unrepressed.[6]

Ovaries

[edit]

RSPO1 is necessary in female sex development. It augments the WNT/β catenin pathway to oppose male sex development. In critical gonadal stages, between six and nine weeks after fertilization, the ovaries upregulate it while the testes downregulate it.[8]

Oral mucosa has been identified as a target tissue for RSPO1. When administered to normal mice, it causes nuclear translocation of β-catenin to this region.[7] Modulation of the WNT/β catenin pathway occurs through the relief of Dkk1 inhibition. This occurrence results in increased basal cellularity, thickened mucosa, and elevated epithelial cell proliferation in the tongue. RSPO1 can therefore potentially aid in the treatment of mucositis, which is characterized by inflammation of the oral cavity. This unfortunate condition often accompanies chemotherapy and radiation in cancer patients with head and neck tumors.[7] RSPO1 has also been shown to promote gastrointestinal epithelial cell proliferation in mice.[5]

References

[edit]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000169218Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000028871Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b c "Entrez Gene: RSPO1 R-spondin homolog (Xenopus laevis)".
  6. ^ a b c d Chassot, A. -A.; Bradford, S. T.; Auguste, A.; Gregoire, E. P.; Pailhoux, E.; De Rooij, D. G.; Schedl, A.; Chaboissier, M. -C. (2012). "WNT4 and RSPO1 together are required for cell proliferation in the early mouse gonad". Development. 139 (23): 4461–4472. doi:10.1242/dev.078972. PMID 23095882.
  7. ^ a b c Zhao, J.; Kim, K. -A.; De Vera, J.; Palencia, S.; Wagle, M.; Abo, A. (2009). "R-Spondin1 protects mice from chemotherapy or radiation-induced oral mucositis through the canonical Wnt/ -catenin pathway". Proceedings of the National Academy of Sciences. 106 (7): 2331–2336. doi:10.1073/pnas.0805159106. PMC 2650156. PMID 19179402.
  8. ^ Tomaselli, S.; Megiorni, F.; Lin, L.; Mazzilli, M. C.; Gerrelli, D.; Majore, S.; Grammatico, P.; Achermann, J. C. (2011). Lee, Sean (ed.). "Human RSPO1/R-spondin1 is Expressed during Early Ovary Development and Augments β-Catenin Signaling". PLOS ONE. 6 (1): e16366. Bibcode:2011PLoSO...616366T. doi:10.1371/journal.pone.0016366. PMC 3030573. PMID 21297984.

Further reading

[edit]
[edit]